According to our latest research, the global Angiotensin Converting Enzyme (ACE) Inhibitors market size reached USD 7.4 billion in 2024, with a steady growth trajectory observed over the past few years. The market is projected to expand at a CAGR of 3.8% during the forecast period, reaching USD 10.1 billion by 2033. The primary growth factor for the ACE inhibitors market is the rising prevalence of cardiovascular diseases, particularly hypertension and heart failure, which continues to drive demand for effective and accessible antihypertensive therapies. https://growthmarketreports.com/report/angiotensin-converting-enzyme-inhibitors-market-global-industry-analysis